IntroductionDetermine if employment of Platelet-Rich Plasma in patients subject to hip arthroscopy diminishes postoperative pain, morphine requirements, edema and ecchymosis.MethodsA randomized, prospective, double blinded, placebo controlled clinical trial was conducted. Patients undergoing hip arthroscopy for FAI were offered participation in the study. 60 patients were randomly assigned to receive PRP clot (PRP-C), PRP spray (PRP-S) or saline control (C), wich was located or instilled over the femoral neck osteoplasty. Pain was measured with Visual Analogue Scale (VAS) at 12, 24 hours and 7 days PO. Morphine requirements were registered in the period between 0-12 and 12-24 hours. Diameter of the thigh was assessed preoperatively, 7 and 14 days PO. Ecchymosis at 7 and 14 days PO was graded and registered.ResultsThere were no difference between the groups regarding pain, morphine requirements or edema p>0,05. We found ecchymosis in 66% of the control group at 7 days and 56% at 14 days. In PRP-S group, 55% and 25% had ecchymosis at 7 and 14 days. In PRP-C group, 22% and none had ecchymosis at 7 and 14 days, respectively, with p=0,025 to control group.ConclusionThe use of PRP clot may have some advantages in the postoperative management of patients who undergo hip arthroscopy. The lower ecchymosis suggests an anti-inflammatory effect that may reflect on long term results. IntroductionDetermine if employment of Platelet-Rich Plasma in patients subject to hip arthroscopy diminishes postoperative pain, morphine requirements, edema and ecchymosis. Determine if employment of Platelet-Rich Plasma in patients subject to hip arthroscopy diminishes postoperative pain, morphine requirements, edema and ecchymosis. MethodsA randomized, prospective, double blinded, placebo controlled clinical trial was conducted. Patients undergoing hip arthroscopy for FAI were offered participation in the study. 60 patients were randomly assigned to receive PRP clot (PRP-C), PRP spray (PRP-S) or saline control (C), wich was located or instilled over the femoral neck osteoplasty. Pain was measured with Visual Analogue Scale (VAS) at 12, 24 hours and 7 days PO. Morphine requirements were registered in the period between 0-12 and 12-24 hours. Diameter of the thigh was assessed preoperatively, 7 and 14 days PO. Ecchymosis at 7 and 14 days PO was graded and registered. A randomized, prospective, double blinded, placebo controlled clinical trial was conducted. Patients undergoing hip arthroscopy for FAI were offered participation in the study. 60 patients were randomly assigned to receive PRP clot (PRP-C), PRP spray (PRP-S) or saline control (C), wich was located or instilled over the femoral neck osteoplasty. Pain was measured with Visual Analogue Scale (VAS) at 12, 24 hours and 7 days PO. Morphine requirements were registered in the period between 0-12 and 12-24 hours. Diameter of the thigh was assessed preoperatively, 7 and 14 days PO. Ecchymosis at 7 and 14 days PO was graded and registered. ResultsThere were no difference between the groups regarding pain, morphine requirements or edema p>0,05. We found ecchymosis in 66% of the control group at 7 days and 56% at 14 days. In PRP-S group, 55% and 25% had ecchymosis at 7 and 14 days. In PRP-C group, 22% and none had ecchymosis at 7 and 14 days, respectively, with p=0,025 to control group. There were no difference between the groups regarding pain, morphine requirements or edema p>0,05. We found ecchymosis in 66% of the control group at 7 days and 56% at 14 days. In PRP-S group, 55% and 25% had ecchymosis at 7 and 14 days. In PRP-C group, 22% and none had ecchymosis at 7 and 14 days, respectively, with p=0,025 to control group. ConclusionThe use of PRP clot may have some advantages in the postoperative management of patients who undergo hip arthroscopy. The lower ecchymosis suggests an anti-inflammatory effect that may reflect on long term results. The use of PRP clot may have some advantages in the postoperative management of patients who undergo hip arthroscopy. The lower ecchymosis suggests an anti-inflammatory effect that may reflect on long term results.